Alzamend Neuro ALZN 深 滬
等待開盤 10-08 09:30:00 美东时间
1.38
+0.010
+0.73%
華盛通- 最 高1.42
- 今 開1.34
- 成交量 1.88万股
- 最 低 1.34
- 昨 收 1.37
- 總市值 665.95万
- 52周最高 2.68
- 市盈率 靜 --
- 換手率 0.39%
- 52周最低 0.84
- 委 比 94.87%
- 總股本 482.57万
- 歷史最高 45292.50
- 量 比 0.20
- 振 幅 5.84%
- 歷史最低 0.84
- 每 手 1
- 風險率 0.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Alzamend Neuro Highlights Early AL001 Brain Lithium Data
An update from Alzamend Neuro ( ($ALZN) ) is now available. Alzamend Neuro, Inc...
09-29 18:57
Alzamend Neuro regains Nasdaq compliance
Alzamend Neuro (ALZN) received a notification letter from Nasdaq dated September 14, 2026, informing Alzamend that it has regained compliance. In the compliance notice, Nasdaq stated that Alzamend co...
09-16 20:35
Alzamend Neuro Regains Compliance with Nasdaq Listing Standards
ATLANTA, Sept. 16, 2026 /PRNewswire/ -- Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of...
09-16 20:00
Alzamend Neuro Q1 EPS $(0.68) Misses $(0.56) Estimate, Sales $0.00, Same YoY
Alzamend Neuro (NASDAQ:ALZN) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.56) by 21.43 percent. This is a 46.88 percent increase over losses of $(1.28) per share from the same period last year. The company reported $0.00 in sales this quarter. Thi...
09-11 05:23
美股前瞻 | 史诗级“轧空”来袭！比特币升破7.2万美元；业绩股齐遇冷！沃尔玛盘前大跌逾6%，阿里、网易均跌近4%
史诗级“轧空”来袭！比特币升破7.2万美元，Strategy盘前涨逾9%；业绩股齐遇冷！沃尔玛盘前大跌逾6%，阿里、网易均跌近4%；SK海力士达成重要劳资协议！或加薪逾6%>>
08-20 20:22
美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
Palo Alto To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised the price target for Mercury Systems Inc (NASDAQ:MRCY) from $126 to $131. Piper Sandler a...
08-19 20:23
Ascendiant Capital Maintains Buy on Alzamend Neuro, Raises Price Target to $26
Ascendiant Capital analyst Edward Woo maintains Alzamend Neuro (NASDAQ:ALZN) with a Buy and raises the price target from $25 to $26.
08-19 18:06
Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop
ISMRM Workshop on Beyond Protons: Challenges and Advances in X-Nuclei MR will be held September 28 – October 1, 2026 at the Universitat Oberta de Catalunya (UOC) in Barcelona, Spain Presentation will report first-of-its-kind pharmacokinetic imaging results from Phase 1/2A trial of AL001, Alzamend's ...
08-18 20:06
Alzamend Neuro Signs $25M Securities Purchase Agreement With Ault Lending; Alzamend Receives $7.5M In Gross Proceeds Form Initial Tranche
Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorder ("MDD") and post-traumatic stress disorder ("PTSD"), announce...
08-04 20:12
